Indivior Pharmaceuticals Inc (INDV)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Indivior Pharmaceuticals Inc

Healthcare (1092)

804-379-1090

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

최신 SEC 제출 서류

INDV's Discussions on Twitter

Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
INDV Indivior Pharmaceuticals Inc	40.54	4.80B	1.29B	251.00M	-193.86M	1.9744
TAK Takeda Pharmaceutical Co Adr	17.15	53.43B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.10	44.52B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.03	37.52B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.56	32.24B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	535.67	22.46B	3.17B	1.29B	1.01B	27.09

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-06	개시	H.C. Wainwright	Buy
2025-07-22	재개	Jefferies	Buy
2025-01-28	개시	Rodman & Renshaw	Buy
2024-07-23	개시	Piper Sandler	Overweight
2024-04-03	개시	Craig Hallum	Buy
2023-07-13	개시	Northland Capital	Outperform

Indivior Pharmaceuticals Inc 주식(INDV)의 최신 뉴스

Indivior Pharmaceuticals Inc (INDV) 재무 분석

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Indivior Pharmaceuticals Inc 주식(INDV)의 최신 뉴스

INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Shows Breakout Setup With Perfect Technical Strength Score - ChartMill

Price to earnings forward of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView

Indivior Pharmaceuticals Inc (INDV) Insider Sell: Christian Heid - GuruFocus

Form 144 Indivior Pharmaceuticals For: 10 July By Investing.com - Investing.com Nigeria

INDV (NASDAQ: INDV) files Form 144 reporting 18,586 shares and $764,628 value - Stock Titan

Enterprise value to EBIT forward of Indivior Pharmaceuticals, Inc. – DUS:E7P - TradingView

How Indivior’s Multi-Index Russell 2000 Defensive Inclusion (INDV) Has Changed Its Investment Story - simplywall.st

Enterprise value to EBITDA forward of Indivior Pharmaceuticals, Inc. – DUS:E7P - TradingView

Is Indivior Pharmaceuticals (INDV) Fully Valued As Russell 2000 Index Additions Draw Buyers? - simplywall.st

Indivior Pharmaceuticals Inc. (INDV) is on the move, here's why the trend could be sustainable - MSN

Indivior Pharmaceuticals, Inc. Financial Disclosures & Filings - TradingView

Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) - Yahoo Finance

Indivior added to Russell 2000 defensive indices, shares gain visibility with US investors - ad-hoc-news.de

Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Does Indivior (INDV) Joining Multiple Russell 2000 Defensive Indices Recast Its Opioid-Treatment Narrative? - simplywall.st

Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index - marketscreener.com

Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index - marketscreener.com

Indivior Pharmaceuticals, Inc.(NasdaqGS: INDV) added to Russell 2000 Defensive Index - marketscreener.com

Indivior consensus shapes expectations, shares on Nasdaq under analyst scrutiny - ad-hoc-news.de

INDV Forecast — Price Target — Prediction for 2027 - TradingView

Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Price to book forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Price to sales forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Price to book forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Price to sales forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Enterprise value to EBITDA forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Indivior Pharmaceuticals, Inc. Actuals & Estimates (LS:A42086) - TradingView

Indivior Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INDV) - TradingView

Enterprise value to EBIT forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Is Big Pharma's Patent Cliff Driving a New M&A Wave - Kavout | AI

Price to earnings forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

E7P Forecast — Price Target — Prediction for 2027 - TradingView

IBD 50 stock Indivior breaks out amid big fund ownership expansion, strong profit prospects - MSN

Reasons Why Investors Should Consider Betting on Indivior Stock - The Globe and Mail

A42086 Forecast — Price Target — Prediction for 2027 - TradingView

Form 4 Indivior PLC For: 23 June By Investing.com - Investing.com Australia

Indivior Pharmaceuticals (INDV) CEO vests 1.27M shares, 612K for taxes - Stock Titan

Indivior gains new overweight at Barclays on business turnaround - MSN

Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN

Indivior Pharmaceuticals (INDV) Stock Could Be 23% Undervalued As Cost Cut Narrative Builds - Sahm

INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill

INDIVIOR PHARMACEUTICALS INC (INDV) Stock Chart - ChartMill

Indivior stock gains new Overweight at Barclays (INDV:NASDAQ) - Seeking Alpha

Barclays Initiates Indivior at Overweight With $46 Price Target - marketscreener.com

Indivior PLC (INDV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Indivior PLC (INDV) Institutional Confidence - TradingKey

How Investors Are Reacting To Indivior (INDV) Upgraded 2026 Outlook And $175 Million Buyback Plan - Yahoo Finance

Suboxone Tooth Decay Lawsuit Updates for 2026 - Lawsuit Information Center

Indivior's Chief Scientific Officer Sold Over 18,000 Company Shares. Should Investors Worry? - Yahoo Finance

Indivior Pharmaceuticals Inc (INDV) 재무 분석

매출

순이익

현금흐름

주당 순 이익

INDV과 유사한 종목